- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07941284
Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression
A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort
- To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
- To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Muxuan Chen, Doctor
- Telefonnummer: +8613580561916
- E-mail: muxuanchen@126.com
Studiesteder
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina
- Peking University First Hospital
-
Kontakt:
- Bingbing Xiao, Doctor
-
-
Fujian
-
Fuzhou, Fujian, Kina
- Fujian Maternity and Child Health Hospital
-
-
Gansu
-
Lanzhou, Gansu, Kina
- The First Hospital of Lanzhou University
-
Kontakt:
- Haitao Yu, Doctor
-
Lanzhou, Gansu, Kina
- Gansu Provincial Hospital
-
Kontakt:
- Lianhua Wei, Doctor
-
-
Guangdong
-
Chaozhou, Guangdong, Kina
- Chaozhou Central Hospital
-
Kontakt:
- Fen lin, Doctor
-
Foshan, Guangdong, Kina
- Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
-
Kontakt:
- Chaoxin Jiang, Doctor
-
Guangzhou, Guangdong, Kina
- The First Affiliated Hospital, Sun Yat-sen University
-
Kontakt:
- Bin Huang, Doctor
-
Guangzhou, Guangdong, Kina
- Nanfang Hospital, Southern Medical University
-
Kontakt:
- Dehua Sun, Doctor
-
Guangzhou, Guangdong, Kina
- The Fifth Affiliated Hospital of Southern Medical University
-
Kontakt:
- Xiaoyan Li, Doctor
-
Guangzhou, Guangdong, Kina
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Kontakt:
- Yingchun Zhou, Doctor
-
Guangzhou, Guangdong, Kina
- The Fifth Affiliated Hospital of Guangzhou Medical University
-
Kontakt:
- Liang Peng, Doctor
-
Guangzhou, Guangdong, Kina
- The Third Affiliated Hospital of Southern Medical University
-
Kontakt:
- Xuefeng Wang, Doctor
-
Guangzhou, Guangdong, Kina
- The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Kontakt:
- Kewei Zhao, Doctor
-
Guangzhou, Guangdong, Kina
- Zhujiang Hospital of Southern Medical University
-
Guangzhou, Guangdong, Kina
- Guangzhou Baiyun District Taihe People's Hospital
-
Huizhou, Guangdong, Kina
- Huizhou Municipal Central Hospital
-
Kontakt:
- Xianjin Wu, Doctor
-
Shaoguan, Guangdong, Kina
- Yuebei People's Hospital
-
Kontakt:
- Pingsen Zhao, Doctor
-
Shenzhen, Guangdong, Kina, 518028
- Shenzhen Maternity & Child Healthcare Hospital
-
Kontakt:
- Yuting Dai
- Telefonnummer: 0755-82869849
-
Shenzhen, Guangdong, Kina
- Luohu District People's Hospital
-
Shenzhen, Guangdong, Kina
- Southern Medical University Shenzhen Hospital
-
Kontakt:
- Hongwei Zhou, Doctor
-
Shenzhen, Guangdong, Kina
- The Seventh Affiliated Hospital, Sun Yat-sen University
-
Kontakt:
- Zhaofan Luo, Doctor
-
Zhongshan, Guangdong, Kina
- Zhongshan Xiaolan People's Hospital
-
Kontakt:
- Wandang Wang, Doctor
-
Zhuhai, Guangdong, Kina
- Zhuhai Maternal and Child Health Hospital
-
-
Guangxi
-
Nanning, Guangxi, Kina
- The First Affiliated Hospital of Guangxi Medical University
-
Kontakt:
- Faquan Lin, Doctor
-
-
Guizhou
-
Guiyang, Guizhou, Kina
- Affiliated Hospital of Guizhou Medical University
-
Kontakt:
- Fan Lu, Doctor
-
Zunyi, Guizhou, Kina
- Zunyi First People's Hospital
-
Kontakt:
- Kaifeng Wu, Doctor
-
-
Hainan
-
Haikou, Hainan, Kina
- Hainan General Hospital
-
Kontakt:
- Bo Wang, Doctor
-
-
Heilongjiang
-
Mudanjiang, Heilongjiang, Kina
- Hongqi Hospital Affiliated to Mudanjiang Medical University
-
Kontakt:
- Chunxia Guo, Doctor
-
Qiqihar, Heilongjiang, Kina
- Qiqihar First Hospital
-
-
Henan
-
Zhengzhou, Henan, Kina
- Henan Provincial People's Hospital
-
Kontakt:
- Jing Zhao, Doctor
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, Kina
- Inner Mongolia Autonomous Region Maternal and Child Health Hospital
-
Kontakt:
- Jing Sha, Doctor
-
-
Jiangsu
-
Lianyungang, Jiangsu, Kina
- The Second People's Hospital of Lianyungang
-
Kontakt:
- Wei Liang, Doctor
-
-
Jilin
-
Jilin City, Jilin, Kina
- Jilin City Central Hospital
-
Kontakt:
- Guijie Zhang, Doctor
-
-
Liaoning
-
Shenyang, Liaoning, Kina
- The First Hospital of China Medical University
-
Kontakt:
- Ruizhe Wang, Doctor
-
-
Ningxia
-
Yinchuan, Ningxia, Kina
- General Hospital of Ningxia Medical University
-
Kontakt:
- Feng Li, Doctor
-
-
Qinghai
-
Xining, Qinghai, Kina
- Qinghai Red Cross Hospital
-
Kontakt:
- Dengyun Ma, Doctor
-
-
Shandong
-
Jinan, Shandong, Kina
- Jinan Central Hospital
-
Kontakt:
- Shuyi Han, Doctor
-
Jinan, Shandong, Kina
- Shandong Provincial Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina
- Shanghai East Hospital, Tongji University
-
Kontakt:
- Jingxin Cheng, Doctor
-
-
Shanxi
-
Changzhi, Shanxi, Kina
- Changzhi People's Hospital
-
Kontakt:
- Guoxiang Zhang, Doctor
-
-
Sichuan
-
Dazhou, Sichuan, Kina
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital
-
Kontakt:
- Xuesu He, Doctor
-
Luzhou, Sichuan, Kina
- Affiliated Hospital of Southwest Medical University
-
Kontakt:
- Jinbo Liu, Doctor
-
-
Tibet
-
Lhasa, Tibet, Kina
- Tibet Autonomous Region People's Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.
Beskrivelse
Inclusion Criteria:
- Female aged 18 to 60 years.
- Participants who previously participated in the baseline of the CALM2004 study.
- Volunteers who are recruited through targeted invitations and consent to participate in this study.
Exclusion Criteria:
- Pregnant women.
- Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
- Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
CALM2004 Follow-up Cohort
A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cumulative incidence of CIN2+ at 5 years
Tidsramme: 5 years
|
The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline |
5 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
New incidence and progression rates of ASC-US+ cytological abnormalities
Tidsramme: 5 years
|
ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology. |
5 years
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Tidsramme: 5 years
|
HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up. |
5 years
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studiestol: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Genitale sygdomme
- Patologiske processer
- Sygdomsegenskaber
- Infektioner
- Virussygdomme
- Overførbare sygdomme
- Seksuelt overførte sygdomme, virale
- DNA-virusinfektioner
- Tumorvirusinfektioner
- Patologiske tilstande, tegn og symptomer
- Seksuelt overførte sygdomme
- Papillomavirus infektioner
Andre undersøgelses-id-numre
- CALM2004-5
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .